Table 3

Standardised scores (%) on the AGREE instrument assigned to included CPGs/consensus

GuidelinesDomain (%)AGREE overall assessmentRadar map area (%)
Scope and purposeStakeholder involvementRigour of developmentClarity and presentationApplicabilityEditorial independenceScore (%)
Guidelines from Europe
 SIGN81.594.489.692.666.766.777.8●●●67.5
 NICE878787.585.273.663.988.9●★★65.3
 KCE87.18785.488.941.77572.2●●●58.3
 SIOG64.95056.98734.747.272.2★★★31.3
 AGO64.820.449.353.723.675.155.6★★▲21.5
 EUSOMA68.540.726.472.223.644.450.0.★★★20.4
 ESMO62.931.543.879.612.558.355.6★★★19.3
 SEOM70.427.830.640.76.933.322.2★▲▲7.6
Guidelines from North America
 ASCO92.677.888.283.361.191.794.4●●●67.7
 CCO92.661.186.983.334.788.972.2●●★54
 NCCN61.175.979.981.551.466.772.2●●★48.2
 SSO-ASTRO90.731.576.48712.57577.8●★★34.6
 ACR61.131.465.951.915.35055.6★★★20
 SASK57.41314.668.513.98.344.4▲▲▲5.8
Guidelines from Asian and Pacific region
 Malaysia92.674.168.185.231.97572.2●●●59.6
 NZGG8766.777.888.956.988.977.8●●★49.6
 CA- BRCA81.568.554.977.847.288.977.8●●★47.9
 CA-NBOCC81.538.954.975.931.98.355.6★★★21.4
 JBCS57.424.127.155.64.230.638.9★★▲9.4
Consensus statements
 Biedenkopf74.135.231.375.919.463.744.4★★★22.6
 St. Gallen66.731.527.870.418.166.738.9★★★19.8
 ESO74.127.831.383.212.55033.3★★★18.2
 D.A.C.H.77.825.936.157.48.341.744.4★★▲15.1
  • ●, recommend; ★, recommend with modification; ▲, not recommended.

  • AGO, German Group for Gynecological Oncology; ESMO, European Society for Medical Oncology; NCCN, National Comprehensive Cancer Network; JBCS ,Japanese Breast Cancer Society; ASCO, American Society of Clinical Oncology; NCIE ,National Institute for Health and Care Excellence; CCO, Cancer Care Ontario; SIGN ,Scottish Intercollegiate Guidelines Network; ACR, American College of Radiology; KCE, Belgium Health Care Knowledge Center; SSO-ASTRO, Society of Surgical Oncology-American Society for Radiation oncology; SEOM, Spanish Society of Medical Oncology; EUSOMA, European Society of Breast Cancer Specialists; CA-NBOCC ,Cancer Australia-National Breast and Ovarian Cancer Center; SASK, Saskatchewan Cancer Agency, Malaysia Academy of Medicine of Malaysia; SIOG, Society of Geriatric Oncology; NZGG, New Zealand Guidelines Group; D.A.C.H, German, Australia, Swiss Societies of Senelogy, St Gallen St Gallen Consensus; ESO, European School of Oncology, Biedenkopf the Biedenkopf expert panel members.